Abstract

Animal and transcranial magnetic stimulation motors have evoked potential studies suggesting that the currently used transcranial direct current stimulation (tDCS) intensities produce measurable physiological changes. However, the validity, mechanisms, and general efficacy of this stimulation modality are currently being scrutinized. The purpose of this pilot study was to investigate the effects of dorsolateral prefrontal cortex tDCS on cerebral blood flow. A sample of three people with multiple sclerosis underwent two blocks of five randomly assigned tDCS intensities (1, 2, 3, 4 mA, and sham; 5 min each) and [15O]water positron emission tomography imaging. The relative regional (i.e., areas under the electrodes) and global cerebral blood flow were calculated. The results revealed no notable differences in regional or global cerebral blood flow from the different tDCS intensities. Thus, 5 min of tDCS at 1, 2, 3, and 4 mA did not result in immediate changes in cerebral blood flow. To achieve sufficient magnitudes of intracranial electrical fields without direct peripheral side effects, novel methods may be required.

Highlights

  • Multiple sclerosis (MS) is a chronic central nervous system disease that affects approximately2.3 million people worldwide [1]

  • Though motor evoked potential (MEP) amplitude appears to be sensitive to transcranial direct current stimulation (tDCS) modulation, other reliable transcranial magnetic stimulation (TMS) measures that rely on similar neural mechanisms (e.g., short interval intracortical inhibition (SICI), intracortical facilitation (ICF), and cortical silent period) have all shown no tDCS effect

  • The results revealed no notable differences in the gCBF or regional CBF (rCBF) for the areas under the electrodes

Read more

Summary

Introduction

Multiple sclerosis (MS) is a chronic central nervous system disease that affects approximately2.3 million people worldwide [1]. Because some MS symptoms (e.g., neuropathic pain) are treatment-resistant [2], practical and inexpensive adjunctive therapies, like transcranial direct current stimulation (tDCS), are of high interest. Despite promising findings in tDCS studies in people with multiple sclerosis (PwMS) [3,4,5] (see [6] for a review), the validity and utility of tDCS is under scrutiny. A critical review [7] did not support the idea that tDCS has a reliable neurophysiological effect beyond motor evoked potential (MEP) amplitude modulation. Though MEP amplitude appears to be sensitive to tDCS modulation, other reliable transcranial magnetic stimulation (TMS) measures that rely on similar neural mechanisms (e.g., short interval intracortical inhibition (SICI), intracortical facilitation (ICF), and cortical silent period (cSP)) have all shown no tDCS effect. Questions concerning the mechanistic foundations and general efficacy of this stimulation modality are on the rise

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.